CSPC PHARMACEUT.GR. ADR4 (CVGU) — Free Cash Flow Generation Index

Latest as of December 2025: 0.61x

CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Free Cash Flow Generation Index of 0.61x as of December 2025. Free cash flow of €3.55 Billion represents 1% of operating cash flow (€5.83 Billion). See CSPC PHARMACEUT.GR. ADR4 short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.61x
Free Cash Flow / Operating CF

Free Cash Flow

€3.55 Billion
EUR

Operating Cash Flow

€5.83 Billion
EUR

Capital Expenditures

€2.28 Billion
EUR

CSPC PHARMACEUT.GR. ADR4 Free Cash Flow Generation Index (2021–2025)

Historical FCF Generation Index trend for CSPC PHARMACEUT.GR. ADR4 across 5 annual periods. Explore CSPC PHARMACEUT.GR. ADR4 (CVGU) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for CSPC PHARMACEUT.GR. ADR4 (2021–2025)

Year-by-year Free Cash Flow Generation Index for CSPC PHARMACEUT.GR. ADR4. For the full company profile including market capitalisation, see CSPC PHARMACEUT.GR. ADR4 stock valuation.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2025 0.61x €3.55 Billion €5.83 Billion €2.28 Billion ▲ +48.8%
2024 0.41x €1.86 Billion €4.53 Billion €2.68 Billion ▼ -25.2%
2023 0.55x €2.29 Billion €4.18 Billion €1.89 Billion ▼ -14.9%
2022 0.64x €4.90 Billion €7.63 Billion €2.72 Billion ▲ +3.6%
2021 0.62x €2.88 Billion €4.64 Billion €1.76 Billion
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).